SavedAdd your journal

Journals / MN Kardiyoloji / 2022 / Cilt: 29 - Sayı: 1

Assessment of Acetylsalicylic Acid Treatment on Prevention of Cardiovascular Events in Patients with Non-Obstructive Coronary Artery Stenosis

Tıkayıcı Olmayan Koroner Arter Darlığında Asetilsalisilik Asitin Kardiyovasküler Olay Gelişimini Önlemede Etkisinin Değerlendirilmesi

Kerim ESENBOĞA
Ebru ŞAHİN
Türkan Seda TAN
İrem DİNÇER
Ayşe İrem DEMİRTOLA
Kübra KORKMAZ
Pages
34–39
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Material and Method: A total of 415 patients with

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Acetylsalicylic acid is one of the most used drugs for primary and secondary prevention of cardiovascular diseases.
📊
Key Findings & Data:Acetylsalicylic acid is not prescribed to all patients for primary prevention and acetylsalicylic acid usage is still controversial for patients with non‐obstructive coronary artery stenosis.
💡
Conclusion & Impact:Material and Method: A total of 415 patients with
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Acetylsalicylic acid is one of the most used drugs for primary and secondary prevention of cardiovascular diseases. Acetylsalicylic acid is not prescribed to all patients for primary prevention and acetylsalicylic acid usage is still controversial for patients with non‐obstructive coronary artery stenosis. We sought to investigate whether acetylsalicylic acid treatment prevent cardiovascular events in patients with non‐obstructive coronary artery stenosis. Material and Method: A total of 415 patients with

Özet

Amaç: Asetilsalisilik asit kardiyovasküler hastalıkların primer ve sekonder korunmasında en çok kullanılan ilaçlar arasında yer almakta‐ dır. Primer korumada kullanımı her hastaya önerilmemekle birlikte tıkayıcı olmayan koroner arter darlığında kullanımı hakkında fikir ay‐ rılıkları devam etmektedir. Çalışmamızda asetilsalisilik asitin tıkayıcı olmayan koroner arter darlığı varlığında kardiyovasküler olay geli‐ şimini önlemede etkisi olup olmadığını araştırmak istedik. Gereç ve Yöntem: Çalışmamıza koroner anjiyografide

🔖

Cite This Article

ESENBOĞA, K., ŞAHİN, E., TAN, T. S., DİNÇER, İ., DEMİRTOLA, A. İ., KORKMAZ, K. (2022). Assessment of Acetylsalicylic Acid Treatment on Prevention of Cardiovascular Events in Patients with Non-Obstructive Coronary Artery Stenosis. MN Kardiyoloji, Cilt: 29 - Sayı: 1, 34–39. https://ajindex.com/articles/581443

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Arnett DK. Blumenthal RS. Albert MA. et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596e646
  2. Malçok Gürel Ö. Eryonucu B. Primer Korumada Antipla telet Ajanlar. Türk Klin KardiyolÖzel Konular. 2013;6(4): 606
  3. McNeil JJ. Nelson MR. Woods RL. et al. Effect of Aspirin on AllCause Mortality in the Healthy Elderly. N Engl J Med. 2018;379(16):151928
  4. Bowman L. Mafham M. Wallendszus K. et al. Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus. N Engl J Med. 2018;379(16):152939
  5. Hwang IC. Lee H. Yoon YE. et al. Risk stratification of non obstructive coronary artery disease for guidance of pre ventive medical therapy. Atherosclerosis. 2019;290:6673
  6. Chow BJ. Small G. Yam Y. et al. Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease: results from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter registry) registry. Arterioscler Thromb Vasc Biol. 2015;35(4):9819
  7. Easton JD. Aunes M. Albers GW. et al. Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes). Circulation. 2017;136(10):90716
  8. Şermin Tetik KA. Kardiyovasküler hastalıklarda trombosit fonksiyon testleri: patofizyolojiden klinik yaklaşıma. Cum huriyet Tıp Derg. 2010;32:26474
  9. Çelik O. Çil C. Aterosklerotik Hastalığın Primer Koruma sında Aspirin Kullanımının Uygunluğu: ASSOS Çalışmasının Altgrup Analizi. Muğla Sıtkı Koçman Üniversitesi Tıp Derg. 2021;8(1):436
  10. Abdelaziz HK. Saad M. Pothineni NVK. et al. Aspirin for Primary Prevention of Cardiovascular Events. J Am Coll Cardiol. 2019;73(23):291529
  11. McNeil JJ. Wolfe R. Woods RL. et al. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly. N Engl J Med. 2018;379(16):150918
  12. Gaziano JM. Brotons C. Coppolecchia R. et al. Use of as pirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a ran domised, doubleblind, placebocontrolled trial. Lancet. 2018;392(10152):103646
  13. Visseren FLJ. Mach F. Smulders YM. et al. 2021